Paul Hastings Advised TD Securities in Forte Biosciences’ Oversubscribed Private Placement

Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.’s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.

The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.

More details can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.